Journal Article

Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID

Alshamrani, Saleh A., Najim, Mustafa A., Rabaan, Ali A., Alshengeti, Amer, Verma, Geetika, Halwani, Muhammad A., Alwarthan, Sara, Alwashmi, Ameen S. S., Al-Ahmed, Shamsah H., AlShehail, Bashayer M., Dhawan, Manish, Alshehri, Ahmad A., Alhajri, Mashael, Garout, Mohammed, Thakur, Nanamika, Al-Abdulhadi, Saleh

2023

Overview

The COVID-19 pandemic has caused havoc all around the world. The causative agent of COVID-19 is the novel form of the coronavirus (CoV) named SARS-CoV-2, which results in immune system disruption, increased inflammation, and acute respiratory distress syndrome (ARDS). T cells have been important components of the immune system, which decide the fate of the COVID-19 disease. Recent studies have reported an important subset of T cells known as regulatory T cells (Tregs), which possess immunosuppressive and immunoregulatory properties and play a crucial role in the prognosis of COVID-19 disease. Recent studies have shown that COVID-19 patients have considerably fewer Tregs than the general population. Such a decrement may have an impact on COVID-19 patients in a number of ways, including diminishing the effect of inflammatory inhibition, creating an inequality in the Treg/Th17 percentage, and raising the chance of respiratory failure. Having fewer Tregs may enhance the likelihood of long COVID development in addition to contributing to the disease’s poor prognosis. Additionally, tissue-resident Tregs provide tissue repair in addition to immunosuppressive and immunoregulatory activities, which may aid in the recovery of COVID-19 patients. The severity of the illness is also linked to abnormalities in the Tregs’ phenotype, such as reduced expression of FoxP3 and other immunosuppressive cytokines, including IL-10 and TGF-beta. Hence, in this review, we summarize the immunosuppressive mechanisms and their possible roles in the prognosis of COVID-19 disease. Furthermore, the perturbations in Tregs have been associated with disease severity. The roles of Tregs are also explained in the long COVID. This review also discusses the potential therapeutic roles of Tregs in the management of patients with COVID-19.

• Publisher: MDPI AG,MDPI
• Subject: Abnormalities / Chemokines / Coronaviruses / COVID-19 / Cytokine storm / Disease / Foxp3 protein / Health aspects / Helper cells / Homeostasis / immune response / Immune system / Immunology / Immunoregulation / Infections / Inflammation / Interleukin 10 / long COVID / Lymphocytes / Lymphocytes T / Medical research / Morphogenesis / Pandemics / Perturbation / Phenotypes / Physiological aspects / Prognosis / Proteins / Respiratory distress syndrome / Review / SARS-CoV-2 / Severe acute respiratory syndrome coronavirus 2 / T cells / T regulatory cells (Tregs) / therapeutics / Transcription factors / Viral diseases / Viral infections